Capacity Worries Fade for Biomanufacturing

July 2, 2003
Jim Miller
Jim Miller

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

Pharmaceutical Technology, Pharmaceutical Technology-07-02-2003, Volume 27, Issue 7

The DSM investment puts biomanufacturing capacity in the spotlight. Contract biomanufacturers are adding new capacity and sponsors are marketing their excess capacity.